Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.
about
Increasing GLP-1 Circulating Levels by Bariatric Surgery or by GLP-1 Receptor Agonists Therapy: Why Are the Clinical Consequences so Different?From neuroanatomy to behavior: central integration of peripheral signals regulating feeding behaviorImpact of postprandial glycaemia on health and prevention of diseasePhysiology of proglucagon peptides: role of glucagon and GLP-1 in health and diseaseVaccination against GIP for the treatment of obesityNon-replication of an association of CTNNBL1 polymorphisms and obesity in a population of Central European ancestry.FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in miceGlucagon-like peptide-1 and glucose-dependent insulinotropic peptide: effects alone and in combination on insulin secretion and glucose disappearance in mice.Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular diseaseGlucagon-like peptide-1 receptor knockout mice are protected from high-fat diet-induced insulin resistanceRat chromosome 8 confers protection against dyslipidemia caused by a high-fat/low-carbohydrate diet.GIP-overexpressing mice demonstrate reduced diet-induced obesity and steatosis, and improved glucose homeostasisGastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass.Differential effects of PPAR-{gamma} activation versus chemical or genetic reduction of DPP-4 activity on bone quality in mice.Neutralizing interleukin-1beta (IL-1beta) induces beta-cell survival by maintaining PDX1 protein nuclear localization.Alterations of glucose-dependent insulinotropic polypeptide and expression of genes involved in mammary gland and adipose tissue lipid metabolism during pregnancy and lactation.Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.GLP-1 based therapeutics: simultaneously combating T2DM and obesity.Phenotypic flexibility as a measure of health: the optimal nutritional stress response testEndoscopic sclerotherapy for the treatment of weight regain after Roux-en-Y gastric bypass: outcomes, complications, and predictors of response in 575 procedures.Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain.Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.Weight-loss diets modify glucose-dependent insulinotropic polypeptide receptor rs2287019 genotype effects on changes in body weight, fasting glucose, and insulin resistance: the Preventing Overweight Using Novel Dietary Strategies trial.Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes.GLP-1(32-36)amide Pentapeptide Increases Basal Energy Expenditure and Inhibits Weight Gain in Obese MiceMice Deficient in Proglucagon-Derived Peptides Exhibit Glucose Intolerance on a High-Fat Diet but Are Resistant to Obesity.Changes seen in gut bacteria content and distribution with obesity: causation or association?Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in miceMango Supplementation Modulates Gut Microbial Dysbiosis and Short-Chain Fatty Acid Production Independent of Body Weight Reduction in C57BL/6 Mice Fed a High-Fat Diet.Peripheral neural targets in obesityCardiovascular biology of the incretin system.Adipokines and the peripheral and neural control of energy balance.Obesity vaccines.Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function.Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency.The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action.The effect of duodenal-jejunal bypass on glucose-dependent insulinotropic polypeptide secretion in Wistar rats.Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetesIntake of Nutrients, Fiber, and Sugar in Patients with Nonalcoholic Fatty Liver Disease in Comparison to Healthy Individuals.Minireview: Meeting the demand for insulin: molecular mechanisms of adaptive postnatal beta-cell mass expansion
P2860
Q26744254-F9651B71-3E36-448D-9B59-BC4F00BD4F32Q26828589-2FB91CF0-9425-4F0A-BDE3-483C12CF770BQ26862823-A68863B4-7573-49F3-8991-9C855665236FQ27027920-3B024DE5-027D-4F28-9779-257AFBF5FD17Q27300376-0D941DC1-1547-4C22-B92E-72ED192F62F2Q33410654-6AD5CFC5-EEA6-451D-936B-D0D66D7C348DQ33559637-8852E805-A179-47EC-8BE9-6AF6551AE9CEQ33800196-C3AEDC97-0409-4B12-A6D1-1B59C4E7A2F6Q33939256-2D6A503B-8E47-4AB5-B38A-5E0062DF1F0EQ34157515-B1321E27-C6B8-48F7-A13C-883D77274871Q34206069-7550F305-8183-4C04-AEF3-54AE7FC8D14AQ34339666-F2EE3035-1830-49EE-931E-194B8804B0A8Q34594267-017B0FF6-2152-47CC-8E8A-390D7B6EF8CDQ34888374-23A58B32-8D58-4380-9477-F3103CEEC753Q34948047-C22EAA6C-0592-488F-BA49-D4A7FFB509C4Q35043520-DF1D1A01-59A1-475C-9C82-66D057058659Q35180081-715D6266-C150-4FEE-857F-96B579714F99Q35200252-EEF2E499-85FF-4A28-80B7-4C970FFB8926Q35501633-248C16E6-1496-4DA6-91A3-087A1EFE6B22Q35596971-5C89042B-ABC6-47E2-A697-368C32CE70FFQ35639940-785150A9-96F7-414C-9404-28DAFFEF7315Q35640531-B3ABA470-E33D-43C8-9144-99339DAC1C63Q35677313-0A3FB275-375A-4EFE-B4EA-FB55CEAB63D9Q35677365-FEA578D9-11DA-4E74-A65B-7E140D585107Q35769544-CA2DA0ED-6903-4E58-A47B-625FFCF7A4A1Q35778163-4B0B7308-5AE6-4209-AD91-86073503E5F5Q35810545-EC9F0305-14B5-4B7E-B63E-B9DE4F2CCA2CQ35929005-B563DFCE-E967-43AD-AF63-5BB2101BBB61Q36064485-349295F5-E7D5-4669-8050-D7C39AA9C002Q36166645-1D2B26E0-419A-4B41-A889-D0EA4BD70501Q36484283-CBDB0CD0-6233-4ED9-A965-FA347CC1083FQ36629302-4885F94D-EF6D-45ED-AC2B-8FFC22AF13ABQ36977740-AC3EBBD4-C76B-426B-8CBE-140B3A4E7A65Q36979291-805515D6-9835-47FC-8CE0-63B8AB8BFAE2Q37015063-1EB5CB94-6BFD-4A71-9C19-4561C950964CQ37125933-7C354DD7-70C4-4AA3-9525-011DDCBCD51AQ37144071-D4AF7D20-C8D5-4F4E-81B0-BA0513444FC6Q37193717-B4B7E159-A90F-4163-8505-3BB49F758F23Q37199710-A5713733-2D26-492E-810A-F39D5701A8CCQ37214986-D39E98E1-3C98-4D0A-837B-6CCA913F6744
P2860
Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@ast
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@en
type
label
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@ast
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@en
prefLabel
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@ast
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@en
P2093
P2860
P356
P1476
Extrapancreatic incretin recep ...... eight, and energy expenditure.
@en
P2093
Adriano Maida
Grace Flock
Katsushi Tsukiyama
Tanya Hansotia
Yuichiro Yamada
Yutaka Seino
P2860
P304
P356
10.1172/JCI25483
P407
P577
2006-12-21T00:00:00Z